Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.55 SEK | -5.07% | +10.51% | +39.39% |
May. 08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.39% | 73.13M | |
+14.99% | 78.65B | |
+9.32% | 8.94B | |
-12.05% | 5.16B | |
+53.66% | 4.85B | |
+11.63% | 4.19B | |
-23.67% | 2.32B | |
+12.07% | 2.29B | |
-32.35% | 2.19B | |
+21.04% | 2.19B |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB
- Transcript : Orexo AB, Q1 2022 Earnings Call, Apr 28, 2022